Analyzing tumor suppressor activities in the murine small intestine

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Tumor suppressor genes play a critical role in preventing cancer by regulating cell death and DNA repair.
• Loss of function in these genes can lead to increased mutation rates and tumor predisposition.

Purpose of the Study:

• To investigate the in vivo consequences of deleting key tumor suppressor genes, including p53, mismatch repair genes (Msh2, Mlh1, Pms2), and Mbd4.
• To determine the relationship between apoptosis, DNA damage, mutation rate, and tumor development.

Main Methods:

• Generation and analysis of genetically engineered mouse models deficient in specific tumor suppressor genes.
• Assessment of DNA damage response, apoptosis, clonogenic survival, mutation rates, and tumorigenesis.
• Intercrossing of p53 and Msh2 mutant mice to study gene interactions.

Main Results:

• p53 deficiency impairs apoptosis in response to DNA damage, leading to increased clonogenic survival and accelerated tumorigenesis with Apc inactivation, but not increased spontaneous mutation rate.
• Deficiency in mismatch repair genes (Msh2, Mlh1, Pms2) results in defective apoptosis, increased clonogenic survival, and elevated mutation rates, strongly suggesting apoptosis loss drives mutation increase.
• Heterozygosity for p53 accelerates microsatellite instability in Msh2 mutant mice, revealing a novel role for p53 in genome stability.
• Mbd4 acts as a tumor suppressor in vivo.

Conclusions:

• Apoptosis plays a key role in preventing mutations and tumor formation, particularly in response to DNA damage.
• p53 and mismatch repair pathways are critical for maintaining genomic integrity and preventing cancer.
• Mbd4 is identified as a novel tumor suppressor gene.